Delivery Order SPE2DB24D2216-SPE2DB24FGMWB

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,430.08 firm fixed-price contract is for the supply of 4,565,405,138 units of Metoprolol Succinate Extended-Release 50 mg tablets, with an ultimate completion date of August 12, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.75 firm fixed-price contract is for the delivery of 4,564,542,315 units of Metoprolol Succinate ER 50 mg tablets. The contract has an ultimate completion date of May 9, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,565,802,734 units of Metoprolol Succinate Extended-Release 100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,308.84 and a period of performance through September 16, 2024. AmerisourceBergen, a for-profit organization, is not subject to any set-aside requirements for this award. The company...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the drug Metoprolol Succinate Extended-Release 50 mg tablets. The contract has a firm fixed price of $2,768.80 and a completion date of July 2, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This contract is part of a larger...
This is a $1,785.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for Metoprolol Succinate Extended-Release 25 mg tablets, with an ultimate completion date of June 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.56 firm fixed-price contract is for the delivery of 4,564,184,960 tablets of Metoprolol Succinate Extended-Release 100 mg. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,987,303 units of Metoprolol Succinate Extended-Release 50 mg Tablets in 1,000-count bottles. The award has a Firm Fixed Price and a total ceiling value of $10,017.50. This is not a Set-Aside contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,098.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of 4,568,076,308 units of Metoprolol Succinate Extended-Release 100 mg Tablets. The contract has a performance period extending through April 30, 2025 and is priced on a firm-fixed-price basis. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPX14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,570,659 units of Metoprolol Succinate Extended-Release 50 mg tablets, a cardiovascular medication, with a ceiling value of $2,001.78. The contract is a Firm Fixed Price Delivery Order with a term extending through March 14, 2025....
This federal contract award, valued at $6,225.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4,565,534,773 units of Metoprolol Succinate Extended-Release 50 mg Tablets in 1,000-count bottles. The contract has a completion date of August 22, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB24FGMWB
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,862,950 units of Metoprolol Succinate Extended-Release 50 mg tablets, which are used to treat hypertension and heart failure. The contract has a ceiling value of $1,878.72 and an ultimate completion date of September 19, 2024. AmerisourceBergen leverages its extensive supply chain to provide a wide range of pharmaceutical and medical products to various federal agencies, including the military. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for delivering critical medical commodities to support government healthcare programs. This specific delivery order contract does not have a set-aside designation.

Generated 12/18/24, 9:16 AM